Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2020 Filed Feb 12, 2020 22:24 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 1,560 | $244.90 | $382,044.00 |
DisclosureSEC source: 0001209191-20-008895 · doc4.xml · nonDerivative · entry 3 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,610 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $244.90 (range $244.37 to $245.33). Read SEC document |
| February 11, 2020 Filed Feb 12, 2020 22:24 UTC |
Silva Paul MSVP & Controller
|
SaleCommon Stock | 380 | $243.59 | $92,564.20 |
DisclosureSEC source: 0001209191-20-008895 · doc4.xml · nonDerivative · entry 2 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,170 F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $243.59 (range $243.29 to $244.28). F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:11 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Tax withholdingCommon Stock | 13,308 | $240.95 | $3,206,562.60 |
DisclosureSEC source: 0001209191-20-008865 · doc4.xml · nonDerivative · entry 1 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,002 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:13 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
Tax withholdingCommon Stock | 8,942 | $240.95 | $2,154,574.90 |
DisclosureSEC source: 0001209191-20-008867 · doc4.xml · nonDerivative · entry 1 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,621 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:14 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 1,181 | $0.00 Strike: $57.27 | $0.00 |
DisclosureSEC source: 0001209191-20-008870 · doc4.xml · derivative · entry 7 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 1,181 shares Expires 2022-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 112 | $244.79 | $27,416.48 |
DisclosureSEC source: 0001209191-20-008870 · doc4.xml · nonDerivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $244.79 (range $244.78 to $244.84). Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 229 | $243.55 | $55,772.95 |
DisclosureSEC source: 0001209191-20-008870 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $243.55 (range $243.46 to $243.72). Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 360 | $242.86 | $87,429.60 |
DisclosureSEC source: 0001209191-20-008870 · doc4.xml · nonDerivative · entry 4 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,216 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $242.86 (range $242.37 to $243.36). Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 360 | $241.61 | $86,979.60 |
DisclosureSEC source: 0001209191-20-008870 · doc4.xml · nonDerivative · entry 3 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,576 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $241.61 (range $241.26 to $241.87). Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:14 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 120 | $240.04 | $28,804.80 |
DisclosureSEC source: 0001209191-20-008870 · doc4.xml · nonDerivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,936 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $240.04 (range $239.59 to $240.49). F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:14 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 1,181 | $57.27 | $67,635.87 |
DisclosureSEC source: 0001209191-20-008870 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:19 UTC |
LEIDEN JEFFREY MDirector · CEO & President
|
Tax withholdingCommon Stock | 36,755 | $240.95 | $8,856,117.25 |
DisclosureSEC source: 0001209191-20-008878 · doc4.xml · nonDerivative · entry 1 LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,063 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:20 UTC |
Parini MichaelEVP, CL&AO
|
Tax withholdingCommon Stock | 13,458 | $240.95 | $3,242,705.10 |
DisclosureSEC source: 0001209191-20-008882 · doc4.xml · nonDerivative · entry 1 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,788 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:22 UTC |
Sachdev AmitEVP, Chief Patient Officer
|
Tax withholdingCommon Stock | 12,215 | $240.95 | $2,943,204.25 |
DisclosureSEC source: 0001209191-20-008889 · doc4.xml · nonDerivative · entry 1 Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,268 Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 22:24 UTC |
Silva Paul MSVP & Controller
|
Tax withholdingCommon Stock | 4,673 | $240.95 | $1,125,959.35 |
DisclosureSEC source: 0001209191-20-008895 · doc4.xml · nonDerivative · entry 1 Silva Paul M · CIK 0001446372 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,550 Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:17 UTC |
Lee YuchunDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $57.27 | $0.00 |
DisclosureSEC source: 0001209191-20-008294 · doc4.xml · derivative · entry 7 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,306 Underlying: Common Stock · 2,000 shares Expires 2022-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Fully vested. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:17 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 600 | $239.96 | $143,976.00 |
DisclosureSEC source: 0001209191-20-008294 · doc4.xml · nonDerivative · entry 6 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $239.96 (range $239.58 to $240.32). Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:17 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 200 | $238.50 | $47,700.00 |
DisclosureSEC source: 0001209191-20-008294 · doc4.xml · nonDerivative · entry 5 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,475 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $238.50 (range $238.41 to $238.59). Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:17 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 700 | $237.51 | $166,257.00 |
DisclosureSEC source: 0001209191-20-008294 · doc4.xml · nonDerivative · entry 4 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,675 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · price: Open market sales reported on this line occurred at a weighted average price of $237.51 (range $236.97 to $237.95). Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:17 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 200 | $236.29 | $47,258.00 |
DisclosureSEC source: 0001209191-20-008294 · doc4.xml · nonDerivative · entry 3 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,375 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F4 · price: Open market sales reported on this line occurred at a weighted average price of $236.29 (range $235.82 to $236.75). Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:17 UTC |
Lee YuchunDirector
|
SaleCommon Stock | 300 | $234.84 | $70,452.00 |
DisclosureSEC source: 0001209191-20-008294 · doc4.xml · nonDerivative · entry 2 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,575 F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $234.84 (range $234.53 to $235.42). F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 21:17 UTC |
Lee YuchunDirector
|
Exercise / conversionCommon Stock | 2,000 | $57.27 | $114,540.00 |
DisclosureSEC source: 0001209191-20-008294 · doc4.xml · nonDerivative · entry 1 Lee Yuchun · CIK 0001334365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,223 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · derivative · entry 11 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,783 Underlying: Common Stock · 1,223 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,303 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · derivative · entry 10 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,642 Underlying: Common Stock · 1,303 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 154 | $242.47 | $37,340.38 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 9 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,310 F4 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 280 | $240.82 | $67,429.60 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 8 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,464 F4 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F6 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $240.82 (range $240.60 to $241.04). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 630 | $239.63 | $150,966.90 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 7 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,744 F4 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F4 · price: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F7 · price: Open market sales reported on this line occurred at a weighted average price of $239.63 (range $239.22 to $240.04). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
SaleCommon Stock | 1,462 | $238.74 | $349,037.88 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 6 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,374 F4 · kind: Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1. F5 · price: Open market sales reported on this line occurred at a weighted average price of $238.74 (range $238.16 to $239.14). F6 · price: Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 1,223 | $155.57 | $190,262.11 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 5 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:07 UTC |
ALTSHULER DAVIDEVP, Global Research and CSO
|
Exercise / conversionCommon Stock | 1,303 | $187.53 | $244,351.59 |
DisclosureSEC source: 0001209191-20-007474 · doc4.xml · nonDerivative · entry 4 ALTSHULER DAVID · CIK 0001550395 · EVP, Global Research and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,223 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · derivative · entry 13 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,783 Underlying: Common Stock · 1,223 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,564 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · derivative · entry 12 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,770 Underlying: Common Stock · 1,564 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 171 | $242.47 | $41,462.37 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 10 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,563 F4 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 150 | $241.08 | $36,162.00 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 9 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,734 F4 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F6 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F9 · price: Open market sales reported on this line occurred at a weighted average price of $241.08 (range $241.04 to $241.12). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 230 | $240.53 | $55,321.90 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 8 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,884 F4 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F6 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F8 · price: Open market sales reported on this line occurred at a weighted average price of $240.53 (range $240.40 to $240.60). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 725 | $239.47 | $173,615.75 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 7 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,114 F4 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F6 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $239.47 (range $239.11 to $240.04). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
SaleCommon Stock | 1,511 | $238.71 | $360,690.81 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 6 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,839 F4 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. F5 · price: Open market sales reported on this line occurred at a weighted average price of $238.71 (range $238.07 to $239.05). F6 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,223 | $155.57 | $190,262.11 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 5 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:08 UTC |
Arbuckle Stuart AEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 1,564 | $187.53 | $293,296.92 |
DisclosureSEC source: 0001209191-20-007477 · doc4.xml · nonDerivative · entry 4 Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 510 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · derivative · entry 10 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,077 Underlying: Common Stock · 510 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,564 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · derivative · entry 9 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,770 Underlying: Common Stock · 1,564 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
SaleCommon Stock | 129 | $242.47 | $31,278.63 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · nonDerivative · entry 8 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,285 F3 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
SaleCommon Stock | 271 | $240.75 | $65,243.25 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · nonDerivative · entry 7 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,414 F3 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F5 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F7 · price: Open market sales reported on this line occurred at a weighted average price of $240.75 (range $240.40 to $241.12). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
SaleCommon Stock | 423 | $239.69 | $101,388.87 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · nonDerivative · entry 6 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,685 F3 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F5 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F6 · price: Open market sales reported on this line occurred at a weighted average price of $239.69 (range $239.20 to $240.19). Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
SaleCommon Stock | 1,251 | $238.76 | $298,688.76 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · nonDerivative · entry 5 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,108 F3 · kind: Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1. F4 · price: Open market sales reported on this line occurred at a weighted average price of $238.76 (range $238.15 to $239.11). F5 · price: Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
Exercise / conversionCommon Stock | 510 | $155.57 | $79,340.70 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · nonDerivative · entry 4 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,359 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:14 UTC |
Kewalramani ReshmaEVP and CMO
|
Exercise / conversionCommon Stock | 1,564 | $187.53 | $293,296.92 |
DisclosureSEC source: 0001209191-20-007485 · doc4.xml · nonDerivative · entry 3 Kewalramani Reshma · CIK 0001735944 · EVP and CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,223 | $0.00 Strike: $155.57 | $0.00 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · derivative · entry 11 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,783 Underlying: Common Stock · 1,223 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2018. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,303 | $0.00 Strike: $187.53 | $0.00 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · derivative · entry 10 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,642 Underlying: Common Stock · 1,303 shares Expires 2029-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:17 UTC |
Parini MichaelEVP, CL&AO
|
SaleCommon Stock | 154 | $242.47 | $37,340.38 |
DisclosureSEC source: 0001209191-20-007505 · doc4.xml · nonDerivative · entry 9 Parini Michael · CIK 0001661567 · EVP, CL&AO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,246 F4 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.